Median overall survival of trimodality eligible patients with locally advanced esophageal adenocarcinoma treated with chemoradiation followed by surgery compared to definitive chemoradiation, using propensity score matchinga (n=48) aPatients matched on age, comorbidity, tumor length, tumor grade, post-treatment biopsy, and post-treatment SUV